Back
Corporate News
Titan Biotech shareholders approved increasing authorized share capital at the annual meeting
30-Sep-2026, 04:50
Titan Biotech Limited informed the BSE Ltd. that at its 34th Annual General Meeting on September 29, 2026, shareholders approved an increase in the company’s authorized share capital from Rs 10,00,00,000 divided into 5,00,00,000 equity shares of Rs 2 each to Rs 10,40,00,000 divided into 5,20,00,000 equity shares of Rs 2 each, resulting in the creation of 20,00,000 new equity shares and a consequent alteration of the “Capital Clause” of the company’s Memorandum of Association.
